Nanalysis Scientific Corp.
OTC:NSCIF
0.3189 (USD) • At close November 15, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 45.495 | 28.466 | 24.821 | 16.043 | 7.874 | 8.364 | 8.381 | 7.668 | 5.252 |
| Cost of Revenue
| 32.749 | 24.495 | 14.352 | 5.803 | 2.707 | 2.304 | 2.983 | 2.774 | 2.147 |
| Gross Profit
| 12.746 | 3.971 | 10.469 | 10.24 | 5.167 | 6.06 | 5.398 | 4.895 | 3.105 |
| Gross Profit Ratio
| 0.28 | 0.139 | 0.422 | 0.638 | 0.656 | 0.725 | 0.644 | 0.638 | 0.591 |
| Reseach & Development Expenses
| 0.544 | 0.679 | 1.465 | 0.643 | 0.476 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 9.673 | 11.041 | 12.414 | 6.14 | 5.534 | 2.774 | 2.256 | 1.315 | 1.325 |
| Selling & Marketing Expenses
| 1.621 | 1.352 | 1.936 | 2.143 | 1.11 | 2.453 | 2.515 | 1.96 | 1.566 |
| SG&A
| 11.294 | 12.393 | 14.35 | 8.283 | 6.644 | 5.227 | 4.771 | 3.275 | 2.891 |
| Other Expenses
| 4.353 | 4.365 | 4.564 | 2.505 | 1.681 | 0.775 | 0.627 | 0 | 0 |
| Operating Expenses
| 16.191 | 15.592 | 20.379 | 11.431 | 8.801 | 5.994 | 5.398 | 3.275 | 2.891 |
| Operating Income
| -3.445 | -11.621 | -9.91 | -1.191 | -3.634 | 0.058 | 0.461 | 1.62 | 0.213 |
| Operating Income Ratio
| -0.076 | -0.408 | -0.399 | -0.074 | -0.462 | 0.007 | 0.055 | 0.211 | 0.041 |
| Total Other Income Expenses Net
| -10.19 | -5.174 | -0.489 | -0.581 | -0.341 | -1.457 | -0.325 | -0.167 | -0.077 |
| Income Before Tax
| -13.635 | -16.795 | -10.399 | -1.772 | -3.975 | -1.399 | 0.136 | 1.452 | 0.136 |
| Income Before Tax Ratio
| -0.3 | -0.59 | -0.419 | -0.11 | -0.505 | -0.167 | 0.016 | 0.189 | 0.026 |
| Income Tax Expense
| -0.022 | -0.011 | -0.484 | 0 | -0.297 | 0.261 | 0.062 | 0.21 | 0.143 |
| Net Income
| -13.613 | -16.784 | -9.915 | -1.772 | -3.678 | -1.66 | 0.074 | -0.172 | -0.025 |
| Net Income Ratio
| -0.299 | -0.59 | -0.399 | -0.11 | -0.467 | -0.198 | 0.009 | -0.022 | -0.005 |
| EPS
| -0.12 | -0.16 | -0.11 | -0.033 | -0.056 | -0.03 | 0.001 | -0.17 | -0.025 |
| EPS Diluted
| -0.12 | -0.16 | -0.11 | -0.033 | -0.056 | -0.03 | 0.001 | -0.17 | -0.025 |
| EBITDA
| -7.664 | -8.848 | -5.261 | 1.376 | -1.864 | 0.903 | 0.66 | 1.784 | 0.324 |
| EBITDA Ratio
| -0.168 | -0.311 | -0.212 | 0.086 | -0.237 | 0.108 | 0.079 | 0.233 | 0.062 |